Clinical Trial Update: Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravitreous injections of Vitrase to induce posterior vitreous detachment; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Posterior Vitreous Detachment

Drugs mentioned

• VITRASE (HYALURONIDASE, OVINE)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Vitreous Detachment, Diabetic Retinopathy | Phase 2 | Status: COMPLETED